PBM
Psyence Biomedical·NASDAQ
--
--(--)
--
--(--)
PBM Filings
Filing Date
Form Description
Form Type
2026-03-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-19
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-19 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-02-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-02-12
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-02-12 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-14 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-13 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
